Trump drug deal to leave NHS with £3bn bill
The NHS is seeking further funding from government to help it absorb extra costs of about £3bn a year arising from a new drug pricing deal, partly inspired by the threat of tariffs on UK medicines made by US president Donald Trump.
HSJ Podcast: The recipe for a new NHS CEO
Sir Jim Mackey is expected to end his tenure as “transition CEO” of NHS England next year, so we discuss what sort of candidate might be up for the “impossible” job of running the health service.
The Integrator: Does neighbourhood health already need a rebrand?
Insider tales and must-read analysis on how integration is reshaping health and care systems, NHS providers, primary care, and commissioning. This week by correspondent Mimi Launder.
